نتایج جستجو برای: gastroesophageal varices

تعداد نتایج: 17466  

2011

Objective: Sinistral, or left-sided, portal hypertension (SPH) is a rare cause of upper gastrointestinal hemorrhage. This retrospective analysis summarizes the clinical features of SPH and the results of surgical treatment. Subjects and Methods: Between 2000 and 2009, patients from our hospital diagnosed with SPH were identified. Diagnosis of SPH was based on evidence of isolated splenic vein t...

Journal: : 2022

Aim. To improve treatment results in patients with the life-threatening complications of cirrhotic portal hypertension by making an informed choice optimal TIPS (transjugular intrahepatic portosystemic shunt) variant. Materials and methods. A total 234 suffering from underwent placement. The indications for shunt placement include esophageal gastric varices exhibiting signs bleeding or carrying...

Journal: :Revista de gastroenterologia de Mexico 2014
F Zárate Mondragón J O Romero Trujillo R Cervantes Bustamante M A Mora Tiscareño E Montijo Barrios J F Cadena León M Cázares Méndez E M Toro Monjaraz J Ramírez Mayans

BACKGROUND Prehepatic portal hypertension in children can be asymptomatic for many years. Once diagnosed, the therapeutic measures (pharmacologic, endoscopic, and surgical) are conditioned by the specific characteristics of each patient. In Mexico, there are no recorded data on the incidence of the disease and patient characteristics. AIMS To determine the main clinical, radiologic, and endos...

2012
Yen-I Chen Peter Ghali

Variceal hemorrhage is one of the major complications of liver cirrhosis associated with significant mortality and morbidity. Its management has evolved over the past decade and has substantially reduced the rate of first and recurrent bleeding while decreasing mortality. In general, treatment of esophageal varices can be divided into three categories: primary prophylaxis (prevention of first e...

2012
Nir Hilzenrat Averell H. Sherker

Portal hypertension is one of the most significant complications of both acute and chronic liver diseases. It generally develops as a result of an increase in vascular resistance at the prehepatic, intrahepatic, or postherpetic level. An increase in portal blood flow may also contribute. The dominant cause of portal hypertension relates to liver cirrhosis which increases resistance through the ...

Journal: :Therapeutic advances in gastroenterology 2014
Isabelle Cremers Suzane Ribeiro

Acute upper gastrointestinal haemorrhage remains the most common medical emergency managed by gastroenterologists. Causes of upper gastrointestinal bleeding (UGIB) in patients with liver cirrhosis can be grouped into two categories: the first includes lesions that arise by virtue of portal hypertension, namely gastroesophageal varices and portal hypertensive gastropathy; and the second includes...

2017
Xiaohang Li Jialin Zhang Yiman Meng Lei Yang Shurong Liu Gang Wu

A patient with friable hepatic artery and poor hepatic arterial inflow, portal vein thrombosis and serious gastroesophageal varices underwent modified piggyback liver transplantation. The hepatic artery was reconstructed by interposing donor’s iliac arterial conduit anastomosed to the infrarenal aorta, while the portal vein flow was ensured by the interposition of donor’s iliac venous graft. Th...

2012
Jaideep U. Barge Jorge E. Lopera

Major vascular complications related to pancreatitis can cause life-threatening hemorrhage and have to be dealt with as an emergency, utilizing a multidisciplinary approach of angiography, endoscopy or surgery. These may occur secondary to direct vascular injuries, which result in the formation of splanchnic pseudoaneurysms, gastrointestinal etiologies such as peptic ulcer disease and gastroeso...

Journal: :Annals of Oncology 2023

Combination Atezolizumab-Bevacizumab (AB) is the current standard of care first-line treatment for patients with advanced hepatocellular carcinoma (HCC). Bevacizumab associated increased risk gastrointestinal bleeding, a concern especially pertinent this group patients. IMBrave150 hence mandated esophago-gastroduodenoscopy (OGD) within 6 months therapy initiation, allowing existing gastroesopha...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید